MedTrace Logo

A Short, Animated Storytelling Video to Boost Psychological Capital

NCT05718973 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10000

Last updated 2023-05-10

No results posted yet for this study

Summary

This study will evaluate the effect of a short, animated storytelling intervention video on positive psychological capital intervention on immediate and medium-term psychological capital and related constructs, gratitude and happiness. We will also measure voluntary engagement with the content of the short, animated storytelling intervention video on positive psychological capital.

In this 4-armed, parallel, randomized controlled trial, 10,000 adult, US participants will be randomly assigned to (1) a short, animated storytelling intervention video on positive psychological capital followed by the psychological capital , gratitude and happiness surveys (2) the surveys only, (3) an attention placebo control video followed by the before mentioned surveys, and (4) an arm that is exposed to neither the video nor the surveys. Two weeks later, participants in all four arms will complete all of the surveys.

The primary outcome is psychological capital (immediate and medium-term). Secondary outcomes are gratitude and happiness (immediate and medium-term) as well as voluntary engagement with the short, animated storytelling video content.

Conditions

  • Psychological Capital

Interventions

OTHER

short, animated storytelling video (intervention video)

Participants in the Intervention Arm will view a short, animated storytelling video designed to promote psychological capital.

OTHER

short, animated storytelling attention placebo video

The Attention Placebo Control Arm will view an attention placebo control video, unrelated to the outcomes measured in this trial.

Sponsors & Collaborators

  • Stanford University

    collaborator OTHER

  • Heidelberg University

    collaborator OTHER

  • University Hospital Freiburg

    lead OTHER

Principal Investigators

  • Till Bärnighausen, Prof. Dr. · Heidelberg University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-01
Primary Completion
2023-07-31
Completion
2023-08-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05718973 on ClinicalTrials.gov